NRx Pharmaceuticals Inc.

NRXP | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.29

-$0.03 (-0.90%)

At close: Sep 21, 2026, 4:00 PM ET

$3.29

$0 (0.00%)

Pre-market: Sep 22, 2026, 6:23 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.90%

(1D)

Rating

Updated: Aug 10, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $56.87M

1D Range

3.29 3.38

52W Range

1.62 5.06

Valuation (TTM)

PE -4.45

PB -334.53

EV/EBITDA -2.57

Valuation (NTM)

Forward PE 8.94

Forward PEG 0.09

Price Target $2

Cash Flow

FCF Yield -36.4%

SBC Adj. FCF Yield -37.1%

SBC Impact -2.1%

Margins

Gross Margin 32.7%

Operating Margin -588.2%

FCF Margin -609.0%

Growth (CAGR)

Revenue 3Y | 5Y 150.0% | 100.0%

Dil EPS 3Y | 5Y 43.2% | 16.8%

FCF 3Y | 5Y -18.4% | 29.4%

Returns

ROA -68.7%

ROE 168.7%

ROIC -1855.5%

Financial Health

Net Cash

$25.85M

Current Ratio 0.86

Interest Coverage -17.45

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative therapies for disorders of the central nervous system and critical lung diseases. Its product port...

Sector Healthcare

Industry Biotechnology

Employees 29

IPO Date Dec 3, 2017

Website www.nrxpharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 13, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Downside

-39.21%

Buy (4)

Hold (0)

Sell (0)

Analyst Details ➞